| The Food and Drug Administration's decision would clear additional shots of the Pfizer-BioNTech vaccine for younger adolescents and would also make boosters available for children 5 to 11 whose immune systems are compromised. The Centers for Disease Control and Prevention and its advisers will review the FDA action, with a recommendation expected midweek. | 
No comments:
Post a Comment